Sung, H. et al. Global Cancer Statistics 2020: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209–249 (2021).

Article  PubMed  Google Scholar 

de Visser, K. E. & Joyce, J. A. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell 41, 374–403 (2023).

Article  PubMed  Google Scholar 

DePeaux, K. & Delgoffe, G. M. Metabolic barriers to cancer immunotherapy. Nat. Rev. Immunol. 21, 785–797 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Almagro, J. et al. Tissue architecture in tumor initiation and progression. Trends Cancer 8, 494–505 (2022).

Article  CAS  PubMed  Google Scholar 

Hanahan, D. Hallmarks of cancer: new dimensions. Cancer Discov. 12, 31–46 (2022).

Article  CAS  PubMed  Google Scholar 

Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell. 144, 646–674 (2011).

Article  CAS  PubMed  Google Scholar 

Papotto, P. H., Ribot, J. C. & Silva-Santos, B. IL-17(+) gammadelta T cells as kick-starters of inflammation. Nat. Immunol. 18, 604–611 (2017).

Article  CAS  PubMed  Google Scholar 

Silva-Santos, B., Mensurado, S. & Coffelt, S. B. gammadelta T cells: pleiotropic immune effectors with therapeutic potential in cancer. Nat. Rev. Cancer 19, 392–404 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mensurado, S., Blanco-Dominguez, R. & Silva-Santos, B. The emerging roles of gammadelta T cells in cancer immunotherapy. Nat. Rev. Clin. Oncol. 20, 178–191 (2023).

Article  CAS  PubMed  Google Scholar 

Ribot, J. C., Lopes, N. & Silva-Santos, B. gammadelta T cells in tissue physiology and surveillance. Nat. Rev. Immunol. 21, 221–232 (2021).

Article  CAS  PubMed  Google Scholar 

Xu, Y. et al. Allogeneic Vgamma9Vdelta2 T-cell immunotherapy exhibits promising clinical safety and prolongs the survival of patients with late-stage lung or liver cancer. Cell Mol. Immunol. 18, 427–439 (2021).

Article  CAS  PubMed  Google Scholar 

Alnaggar, M. et al. Allogenic Vgamma9Vdelta2 T cell as new potential immunotherapy drug for solid tumor: a case study for cholangiocarcinoma. J. Immunother. Cancer 7, 36 (2019).

Article  PubMed  PubMed Central  Google Scholar 

Liang, J. et al. Allogeneic Vgamma9Vdelta2 T-cell therapy promotes pulmonary lesion repair: an open-label, single-arm pilot study in patients with multidrug-resistant tuberculosis. Front. Immunol. 12, 756495 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sebestyen, Z. et al. Translating gammadelta (gammadelta) T cells and their receptors into cancer cell therapies. Nat. Rev. Drug Discov. 19, 169–184 (2020).

Article  CAS  PubMed  Google Scholar 

Deseke, M. & Prinz, I. Ligand recognition by the γδ TCR and discrimination between homeostasis and stress conditions. Cell Mol. Immunol. 17, 914–924 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vantourout, P. & Hayday, A. Six-of-the-best: unique contributions of gammadelta T cells to immunology. Nat. Rev. Immunol. 13, 88–100 (2013).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Silva-Santos, B., Serre, K. & Norell, H. gammadelta T cells in cancer. Nat. Rev. Immunol. 15, 683–691 (2015).

Article  CAS  PubMed  Google Scholar 

Sun, L. et al. T cells in health and disease. Sig. Transduct. Target Ther. 8, 235 (2023).

Article  CAS  Google Scholar 

Qu, G. et al. Comparing mouse and human tissue-resident gammadelta T cells. Front. Immunol. 13, 891687 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Papotto, P. H., Reinhardt, A., Prinz, I. & Silva-Santos, B. Innately versatile: gammadelta17 T cells in inflammatory and autoimmune diseases. J. Autoimmun. 87, 26–37 (2018).

Article  CAS  PubMed  Google Scholar 

Grupp, S. A. et al. Chimeric antigen receptor-modified T cells for acute lymphoid leukemia. N. Engl. J. Med. 368, 1509–1518 (2013).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Porter, D. L. et al. Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia. N. Engl. J. Med. 365, 725–733 (2011).

Article  CAS  PubMed  PubMed Central  Google Scholar 

June, C. H. et al. CAR T cell immunotherapy for human cancer. Science 359, 1361–1365 (2018).

Article  CAS  PubMed  Google Scholar 

Ellebrecht, C. T. et al. Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease. Science 353, 179–184 (2016).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mirzaei, H. R. et al. Prospects for chimeric antigen receptor (CAR) gammadelta T cells: a potential game changer for adoptive T cell cancer immunotherapy. Cancer Lett. 380, 413–423 (2016).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wawrzyniecka, P. A. et al. Chimeric antigen receptor T cells for gamma-delta T cell malignancies. Leukemia 36, 577–579 (2022).

Article  CAS  PubMed  Google Scholar 

Makkouk, A. et al. Allogeneic Vδ1 gamma delta T cells engineered with glypican-3 (GPC3)-specific CAR expressing soluble IL-15 have enhanced antitumor efficacy against hepatocellular carcinoma in preclinical models. J. Clin. Oncol. 39, e14511–e14511 (2021).

Article  Google Scholar 

Saito, H. et al. Complete primary structure of a heterodimeric T-cell receptor deduced from cDNA sequences. Nature 309, 757–762 (1984).

Article  CAS  PubMed  Google Scholar 

Hayday, A. C. et al. Structure, organization, and somatic rearrangement of T cell gamma genes. Cell 40, 259–269 (1985).

Article  CAS  PubMed  Google Scholar 

Lefranc, M.-P. & Rabbitts, T. Two tandemly organized human genes encoding the T-cell γ constant-region sequences show multiple rearrangement in different T-cell types. Nature 316, 464–466 (1985).

Article  CAS  PubMed  Google Scholar 

Murre, C. et al. Human γ-chain genes are rearranged in leukaemic T cells and map to the short arm of chromosome 7. Nature 316, 549–552 (1985).

Article  CAS  PubMed  Google Scholar 

Bank, I. et al. A functional T3 molecule associated with a novel heterodimer on the surface of immature human thymocytes. Nature 322, 179–181 (1986).

Article  CAS  PubMed  Google Scholar 

Brenner, M. B. et al. Identification of a putative second T-cell receptor. Nature 322, 145–149 (1986).

Article  CAS  PubMed  Google Scholar 

Borst, J. et al. A T-cell receptor γ/CD3 complex found on cloned functional lymphocytes. Nature 325, 683–688 (1987).

Article  CAS  PubMed  Google Scholar 

Born, W. et al. Recognition of a peptide antigen by heat shock-reactive γδ T lymphocytes. Science 249, 67–69 (1990).

Article  CAS  PubMed  Google Scholar 

O’Brien, R. L. et al. Stimulation of a major subset of lymphocytes expressing T cell receptor γδ by an antigen derived from Mycobacterium tuberculosis. Cell 57, 667–674 (1989).

Article  PubMed  Google Scholar 

Holoshttz, J. et al. Isolation of CD4-CD8-mycobacteria-reactive T lymphocyte clones from rheumatoid arthritis synovial fluid. Nature 339, 226–229 (1989).

Article  Google Scholar 

Janis, E. M., Kaufmann, S. H., Schwartz, R. H. & Pardoll, D. M. Activation of γδ T cells in the primary immune response to Mycobacterium tuberculosis. Science 244, 713–716 (1989).

Article  CAS  PubMed  Google Scholar